Following the coming into force of the Windsor Agreement on 25 March 2023, we take a look at what this means in practice for the UK pharmaceutical industry.
Background
The Northern Ireland Protocol (the “Protocol”) – a key part of the UK-EU Withdrawal Agreement – was intended to safeguard Northern Ireland’s (“NI”) position as a member of the UK while ensuring the integrity of the 1998 Belfast Good Friday Agreement. However, in practice, since the UK’s departure from the EU on 1 January 2020, many...
April 3, 2023
5 min read
